MCKENZIE JANAK: Open Payments
NPI 1942958756 · BAY CITY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$591 in 17 payments from 8 companies in 2025. Trend: 2023 $526 · 2024 $569 · 2025 $591
Food & beverage: $591
| Company | Payments | Amount |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 4 | $158 |
| AstraZeneca Pharmaceuticals LP | 3 | $156 |
| Novo Nordisk Inc | 2 | $94 |
| Amgen Inc. | 3 | $57 |
| Neurocrine BioSciences, Inc. | 2 | $44 |
| Teva Pharmaceuticals USA, Inc. | 1 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $31 |
| SHIELD THERAPEUTICS INC | 1 | $16 |
Products named: NUZYRA, Ozempic, FARXIGA, REPATHA, INGREZZA, AIRSUPRA, BREZTRI, AUSTEDO XR.
Industry payments across TX — which companies pay providers there.
